Pfizer To Keep Celebrex On Market, But Stop Ads

The U.S. Food and Drug Administration, which said Friday it was considering warning labels for Celebrex or withdrawing the drug from the U.S. market, agreed with Pfizer's decision to halt advertising.
The move covers television, radio, newspaper and magazine advertising, Pfizer spokeswoman Mariann Caprino said.
"We discussed it with the FDA, and we all concurred that it was the appropriate step," Caprino told The New York Times.